Related Articles
Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice
Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway
miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1
Prevention of arachidonic acid‑induced liver injury by controlling oxidative stress‑mediated transglutaminase activation with garlic extracts
A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice